23 hours ago
Hyderābād, IndiaStaff+
Responsibilities
- Design, build, and maintain Python, SQL, Databricks, and Spark/PySpark data ingestion and ETL/ELT pipelines.
- Integrate data from APIs, databases, files, and third-party systems.
- Develop and maintain Python backend services and REST APIs using FastAPI, Flask, or Django.
- Build API integrations for applications and AI agents.
- Design relational and NoSQL schemas, data models, and queries.
- Optimize Spark jobs and Databricks workloads for performance, scalability, and cost.
- Implement data validation, error handling, logging, monitoring, testing, and documentation.
- Troubleshoot pipeline, API, and database issues in development and production environments.
- Participate in Git, code review, CI/CD, and deployment workflows.
- Collaborate with data, backend, AI/ML, product, and application teams.
Requirements
- Master's or bachelor's degree in IT, computer science, or engineering.
- 12–17 years of work experience.
- Strong Python and SQL development skills, including relational databases.
- Hands-on experience with Databricks, Apache Spark/PySpark, data pipelines, and multi-source data integration.
- Experience developing or integrating REST APIs and working with NoSQL databases.
- Experience integrating APIs with AI agents or AI/ML applications.
- Understanding of Spark performance optimization, scalability, and distributed systems.
- Familiarity with Git, testing, debugging, production support, authentication, and authorization for APIs.
- Preferred experience with FastAPI, Flask, Django, Delta Lake, Azure Data Lake, Azure Data Factory, Airflow, Kafka, Docker, or Kubernetes.
- Preferred experience supporting GenAI or machine learning data pipelines.
Tech Stack
Categories
BackendData Engineering
About Amgen
Amgen is a public biotechnology company that discovers, develops, manufactures, and sells biologic and biosimilar therapeutics for patients with serious diseases. Its portfolio and pipeline span oncology, cardiovascular disease, osteoporosis, inflammation, and rare diseases, marketed globally through direct sales and partnerships. Founded in 1980 and headquartered in Thousand Oaks, California (NASDAQ: AMGN), Amgen is a component of the Dow Jones Industrial Average and completed the acquisition of Horizon Therapeutics in 2023.